Sildenafil Citrate Tablet
Product Images NDC 72789-405

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 72789-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789405 Label (72789405)

This is a description of a medication package containing Sildenafil 50mg tablets. The package includes 30 tablets with a National Drug Code of 72789-405-30. The expiration date is 10/2025 and the lot number is H20A11. The tablets are film-coated and each tablet contains Sildenafil Citrate USP equivalent to 50mg of Sildenafil. The package also provides information on how to report side effects and contact the doctor for medical advice. The manufacturer is identified as DPHARMACEUTICALS INCORPORATED based in Oklahoma City, OK. Additionally, the package includes a barcode (GTIN), serial number (SNO), and organoleptic markings.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

This description shows a figure illustrating the average change in standing systolic blood pressure from the initial measurements. The data appears to be related to blood pressure adjustments, possibly in a research or medical setting.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

This is a chart showing the mean standing systolic blood pressure change from baseline in a study involving the medications Doxazosin, Placebo, and Silodosin. The x-axis represents the time intervals (0, 1, 2, 4, 5, 6, 7, 8 weeks) and the y-axis shows the blood pressure measurement changes.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

This text appears to be a scientific figure caption related to a study or clinical trial. It mentions data regarding the mean standing systolic blood pressure change from baseline in relation to the drug Doxazosin. The figure may also include a graph or chart illustrating this change.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

This text appears to be a table showing data related to the assessment or evaluation of a certain product or process. It mentions values such as percentages (4%, 63%, 2%), numerical values (8, 5, 35, 0, 100, 214, 380), and a repeated reference to "Sildenafil citrate." The text also includes the term "Trestment arove," which may suggest a treatment or approval process. The specific details and context of this evaluation are not completely clear from the text provided.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.